Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples